Clinical Trial Update: A Phase I/II Trial of VUM02 Injection for Steroid-refractory Acute Graft-versus-host Disease (SR-aGvHD) Treatment [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial of VUM02 injection for steroid-refractory acute graft-versus-host disease is planned, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Steroid-refractory Acute Graft-versus-host Disease

Drugs mentioned

• VUM02

Snippet

Sponsor: Wuhan Optics Valley Vcanbiopharma Co., Ltd. | Conditions: Steroid-refractory Acute Graft-versus-host Disease | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING